MEDICAL EDUCATION AREAS OF INTEREST
TESARO is committed to supporting educational grants related to our current products and development pipeline for education of healthcare providers, patients and caregivers. Please acquaint yourself with TESARO’s FDA-approved therapy and ongoing clinical trials before submitting a grant request.Our primary areas of interest for 2019 are:
- Ovarian cancer (maintenance therapy, monotherapy, and combination therapy)
- Endometrial cancer (immunotherapy)
TESARO accepts unsolicited grant requests on a rolling basis; however, larger grants linked to medical congresses (e.g. SGO and ASCO) will be reviewed in batches. All submissions must be received at least 45 days prior to the decision date requested. We support educational activities utilizing multiple formats (live, virtual, grand rounds, online, podcasts, video, etc.).
TESARO is interested in requests for multi-support of medical education programs associated with the conferences listed below. TESARO will also review grants for post-conference education related to major conferences, even if the conference is not listed below. Patient-tethered programs that include a CME component are also currently of interest.
|2019 ONS Congress||January 1, 2019|
|2019 Asembia Specialty Pharmacy Summit||January 15, 2019|
|2019 ASCO Annual Meeting||February 1, 2019|
|2019 ASHP Conference for Pharmacy Leaders||May 1, 2019|
|2019 SITC Annual Meeting||August 1, 2019|
|2020 SGO Annual Meeting||September 1, 2019|
|2020 AACR Annual Meeting||November 1, 2019|
|2020 ONS Congress||January 1, 2020|
|2020 Asembia Specialty Pharmacy Summit||January 15, 2020|
|2020 ASCO Annual Meeting||February 1, 2020|
send all questions, comments and non-US grant inquiries to: email@example.com.